Similar articles for PMID: 16618011

Year	Number of Results
1991	1
1996	1
1998	2
1999	1
2000	4
2001	3
2002	3
2003	6
2004	5
2005	10
2006	5
2007	7
2008	13
2009	12
2010	12
2011	11
2012	11
2013	15
2014	16
2015	8
2016	18
2017	18
2018	23
2019	16
2020	11
2021	11
2022	6
2023	2
2024	0

1

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.

Baptista T, Martínez J, Lacruz A, Rangel N, Beaulieu S, Serrano A, Arapé Y, Martinez M, de Mendoza S, Teneud L, Hernández L. Baptista T, et al. Can J Psychiatry. 2006 Mar;51(3):192-6. doi: 10.1177/070674370605100310. Can J Psychiatry. 2006. PMID: 16618011 Clinical Trial.

2

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.

Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH. Wu RR, et al. Am J Psychiatry. 2008 Mar;165(3):352-8. doi: 10.1176/appi.ajp.2007.07010079. Epub 2008 Feb 1. Am J Psychiatry. 2008. PMID: 18245179 Clinical Trial.

3

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.

Baptista T, Rangel N, Fernández V, Carrizo E, El Fakih Y, Uzcátegui E, Galeazzi T, Gutiérrez MA, Servigna M, Dávila A, Uzcátegui M, Serrano A, Connell L, Beaulieu S, de Baptista EA. Baptista T, et al. Schizophr Res. 2007 Jul;93(1-3):99-108. doi: 10.1016/j.schres.2007.03.029. Epub 2007 May 8. Schizophr Res. 2007. PMID: 17490862 Clinical Trial.

4

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA. Klein DJ, et al. Am J Psychiatry. 2006 Dec;163(12):2072-9. doi: 10.1176/ajp.2006.163.12.2072. Am J Psychiatry. 2006. PMID: 17151157 Clinical Trial.

5

Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.

Carrizo E, Fernández V, Connell L, Sandia I, Prieto D, Mogollón J, Valbuena D, Fernández I, de Baptista EA, Baptista T. Carrizo E, et al. Schizophr Res. 2009 Aug;113(1):19-26. doi: 10.1016/j.schres.2009.05.007. Epub 2009 Jun 9. Schizophr Res. 2009. PMID: 19515536 Clinical Trial.

6

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.

Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, He YQ, Liu YJ, Chen JD, Li LH. Wu RR, et al. JAMA. 2008 Jan 9;299(2):185-93. doi: 10.1001/jama.2007.56-b. JAMA. 2008. PMID: 18182600 Clinical Trial.

7

Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.

Wu RR, Jin H, Gao K, Twamley EW, Ou JJ, Shao P, Wang J, Guo XF, Davis JM, Chan PK, Zhao JP. Wu RR, et al. Am J Psychiatry. 2012 Aug;169(8):813-21. doi: 10.1176/appi.ajp.2012.11091432. Am J Psychiatry. 2012. PMID: 22711171 Clinical Trial.

8

Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial.

Baptista T, Rangel N, El Fakih Y, Uzcátegui E, Galeazzi T, Beaulieu S, Araujo de Baptista E. Baptista T, et al. Pharmacopsychiatry. 2009 Jan;42(1):14-9. doi: 10.1055/s-0028-1085438. Epub 2009 Jan 19. Pharmacopsychiatry. 2009. PMID: 19153941 Clinical Trial.

9

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.

Baptista T, Uzcátegui E, Rangel N, El Fakih Y, Galeazzi T, Beaulieu S, de Baptista EA. Baptista T, et al. Psychiatry Res. 2008 May 30;159(1-2):250-3. doi: 10.1016/j.psychres.2008.01.011. Epub 2008 Apr 18. Psychiatry Res. 2008. PMID: 18374423 Clinical Trial.

10

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.

Narula PK, Rehan HS, Unni KE, Gupta N. Narula PK, et al. Schizophr Res. 2010 May;118(1-3):218-23. doi: 10.1016/j.schres.2010.02.001. Epub 2010 Mar 7. Schizophr Res. 2010. PMID: 20207521 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

229 results

Results by year